Which closed-end funds own Astellas Pharma Inc?
4 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $5M. Security type: common equity. Country: Japan. ISIN JP3942400007 · ticker 4503.T.
Holdings are historical filings (report dates May 31, 2026 – Jul 31, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| EOD Allspring Global Dividend Opportunity Fund | Global Equity | 0.64% | $2.3M | 164,700 sh | $352M | 10.2% discount | Jul 31, 2026 |
| IGD Voya Global Equity Dividend & Premium Opportunity Fund | Global Equity | 0.33% | $1.6M | 113,800 sh | $491M | 2.2% discount | May 31, 2026 |
| IGA Voya Global Advantage & Premium Opportunity Fund | Multi-Asset | 0.33% | $533K | 37,400 sh | $161M | 8.0% discount | May 31, 2026 |
| ETW Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund | Covered Call / Option Income | 0.05% | $587K | 43,900 sh | $1.2B | 11.2% discount | Jun 30, 2026 |
4 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Also listed in filings as: Astellas Pharma Inc.
Issuer-level search for “4503.T” → · Compare two funds’ portfolios →